NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

In general I've found few reverse splits that worked well, but it might here, but only after we've seen the TLD and the share price reacts to it. I expect it to reach the dollar range, or more, I really don't know that it's that great an advantage to get on the Nasdaq, but if the company wished to shorten the time to achieving that, I wouldn't fight that hard if they said, let's do a 1 for 2.

Frankly allowing the O/S to exceed a billion shares is no big thing either, people who feel it won't work just need to look at Apple. Without a R/S I still believe we'll see the $4 required for the Nasdaq on approval, and perhaps far sooner on the announcement of a partnership.

The negative connotation of R/S's are reason enough not to do it, stock's rarely do it where they don't lose substantial value between the time it's announced and weeks after it's executed, certainly it can recover after that by why go through the pain.

With the approval of DCVax-L and positive trials data with DCVax-Direct, I believe that a market cap between $10 and $25 billion is certainly possible, if we did have a billion shares outstanding that would give us a $10 to $25 share price. What would the benefit be at that point of having done a R/S, a small one I suggested would mean $20 to $50, but something like a 1 for 10 would give you $100 to $250. I see no advantage to that high a price unless it's gradually earned by building the business.

In the 1990's AMGN had a great business model, IMHO, each time the stock approached $100 they'd split. Splits certainly have a positive sentiment, all total in that decade they'd split a total of 48 to 1. I'm not suggesting a split, at least not until the share price approached $100, not an impossible number if in fact our products work in many cancers, not just GBM.

Gary